FDA — authorised 27 October 2015
- Marketing authorisation holder: AMGEN
- Status: approved
🇺🇸 Imlygic in United States
FDA authorised Imlygic on 27 October 2015
Marketing authorisation
Imlygic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Imlygic approved in United States?
Yes. FDA authorised it on 27 October 2015.
Who is the marketing authorisation holder for Imlygic in United States?
AMGEN holds the US marketing authorisation.